PlainRecalls
FDA Drug Moderate Class II Terminated

Nitrofurantoin Oral Suspension, USP, 25mg/5mL, 230 mL bottle, Rx only, Manufactured by: Novel Laboratories, Inc., Somerset, NJ 08873; Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, MD 21202, NDC 43386-450-11.

Reported: January 9, 2019 Initiated: December 21, 2018 #D-0346-2019

Product Description

Nitrofurantoin Oral Suspension, USP, 25mg/5mL, 230 mL bottle, Rx only, Manufactured by: Novel Laboratories, Inc., Somerset, NJ 08873; Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, MD 21202, NDC 43386-450-11.

Reason for Recall

Subpotent Drug: Expansion of June 2018 recall of lots S700065 and S700619 due to below specification results for assay.

Details

Recalling Firm
LUPIN SOMERSET
Units Affected
23,460 bottles
Distribution
Nationwide in the USA and Puerto Rico.
Location
Somerset, NJ

Frequently Asked Questions

What product was recalled?
Nitrofurantoin Oral Suspension, USP, 25mg/5mL, 230 mL bottle, Rx only, Manufactured by: Novel Laboratories, Inc., Somerset, NJ 08873; Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, MD 21202, NDC 43386-450-11.. Recalled by LUPIN SOMERSET. Units affected: 23,460 bottles.
Why was this product recalled?
Subpotent Drug: Expansion of June 2018 recall of lots S700065 and S700619 due to below specification results for assay.
Which agency issued this recall?
This recall was issued by the FDA Drug on January 9, 2019. Severity: Moderate. Recall number: D-0346-2019.